The African HIV crisis--15 million dead, 25 million infected--hits home in Minnesota
The AIDS drug Ziagen has brought healthy windfalls to the University of Minnesota and GlaxoSmithKline. But it isn't doing anything at all for the millions who are dying of the disease in Africa.
Emily Carter's flirtation with drugs led her from Park Avenue to a bad marriage with the festering streets of New York's Alphabet City. Now, in a collection of stories, Carter recalls the ABCs of addiction--and spells out the terms of a new life in Minnea
Most of those involved are still struggling to grasp that older people not only get HIV, but get it the same way everyone else does.
A new generation of AIDS drugs called protease inhibitors is having dramatic effects--perhaps even pointing to the day when AIDS will be a manageable chronic disease like diabetes. But for a lot of people who had readied themselves to die,